April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Efficient Stage-Specific Differentiation of Human Embryonic Stem Cells Towards Photoreceptors
Author Affiliations & Notes
  • Carla B. Mellough
    Institute of Human Genetics,
    University of Newcastle Upon Tyne, Newcastle, United Kingdom
  • Owen R. Hughes
    Institute of Human Genetics,
    University of Newcastle Upon Tyne, Newcastle, United Kingdom
  • Evelyne Sernagor
    School of Neurology, Neurobiology and Psychiatry,
    University of Newcastle Upon Tyne, Newcastle, United Kingdom
  • David Steel
    Sunderland Eye Infirmary, Tyne and Wear, United Kingdom
  • Majlinda Lako
    Institute of Human Genetics,
    University of Newcastle Upon Tyne, Newcastle, United Kingdom
  • Footnotes
    Commercial Relationships  Carla B. Mellough, None; Owen R. Hughes, None; Evelyne Sernagor, None; David Steel, None; Majlinda Lako, None
  • Footnotes
    Support  Fight for Sight; Newcastle University; BRC; Conselleria de Sanidad (Generalitat Valenciana); Instituto de Salud Carlos III (Ministry of Science and Innovation, Spain).
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2257. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Carla B. Mellough, Owen R. Hughes, Evelyne Sernagor, David Steel, Majlinda Lako; Efficient Stage-Specific Differentiation of Human Embryonic Stem Cells Towards Photoreceptors. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2257.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Outer retinal degeneration with photoreceptor (PR) loss is the cause of many incurable forms of blindness. Cell transplantation remains an important option, particularly in cases where a substantial loss of PRs has already occurred. Recent successes in the field have identified some of the key chemical and biological cues which drive PR derivation; however the efficiency of this process remains limited and usually requires extensive periods in vitro.

Methods: : We have developed a differentiation regime which rapidly and efficiently derives highly enriched populations of PR precursors from human embryonic stem cells (hESC). This method is serum and feeder free and utilises a three-step protocol designed to mimic the events leading to PR genesis during normal retinal development incorporating 1) anterior neural specification, 2) retinal determination and 3) PR specification and differentiation.

Results: : We report that hESC differentiating under our regime over 60 days sequentially acquire markers associated with neural, retinal field and PR cells. By qPCR, flow cytometry and immunocytochemical analysis we demonstrate robust upregulation of neuroectodermal markers NCAM1 (neural cell adhesion molecule 1) and NEUROD (neurogenic differentiation 1) by 30 days, eye development transcription factor PAX6 (paired box 6), retinal progenitor and PR precursor markers CHX10 (ceh-10 homeo domain containing homolog) and CRX (cone-rod homeobox) over days 30 to 45 and PR-specific markers RCVRN (recoverin), OPN1SW (opsin 1), Rhodopsin and ARR3 (arrestin 3) over days 45 to 60. In an adapted version of our protocol we also demonstrate the efficient production of retinal pigmented epithelium (RPE), an additional important replacement cell type for retinal stem cell therapy.

Conclusions: : The development of more efficient methods by which to derive de novo PRs for cell replacement in outer retinal degeneration has clear implications. Our differentiation regime robustly and efficiently yields expandable populations of enriched PR or RPE precursors from hESC with higher efficiency and in a shorter time frame than what has been published previously.

Keywords: photoreceptors • degenerations/dystrophies 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×